Yanyan Zhang

机构：Donghua University, Chinese Academy of Sciences, First Affiliated Hospital of Jiangxi Medical College, Beijing National Laboratory for Molecular Sciences, Sanofi (China) · ORCID：0000-0002-4229-1470

发表论文 145 篇 · 总被引 2560 次 · h-index 31

代表论文

• Demethylzeylasteral induces PD-L1 ubiquitin–proteasome degradation and promotes antitumor immunity via targeting USP22 (2024 · Acta Pharmaceutica Sinica B · 被引 33)
• Nickel‐Catalyzed Markovnikov‐Selective Hydrodifluoromethylation of Alkynes Using BrCF 2 H (2023 · Angewandte Chemie International Edition · 被引 17)
• 5,7,4′‐Trimethoxyflavone triggers cancer cell PD‐L1 ubiquitin–proteasome degradation and facilitates antitumor immunity by targeting HRD1 (2024 · MedComm · 被引 16)
• The AST/ALT ratio predicts survival and improves oncological therapy decisions in patients with non-small cell lung cancer receiving immunotherapy with or without radiotherapy (2024 · Frontiers in Oncology · 被引 9)
• Flurbiprofen microneedle patches for the management of acute postoperative pain (2024 · Nano Research · 被引 9)
• Phosphorylation of the AMPARs regulated by protein kinase C (PKC) and protein interacting with C-kinase 1 (PICK1) contribute to orofacial neuropathic pain (2023 · Brain Research · 被引 9)